Fusen Pharmaceutical Company Limited (1652.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 531.23M |
| Enterprise Value | 771.7M |
| P/E Ratio | -246.74 |
| PEG Ratio | -1 |
| Price/Sales Ratio | 2.11 |
| Price/Book Ratio | 1.69 |
| Enterprise/Revenue | 2.93 |
| Enterprise/EBITDA | 21.48 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.01 |
| Operating Margin | 0.05 |
AD
Management Effectiveness
| Return On Assets | -0 |
| Return On Equity | -0.01 |
Income Statement
| Revenue | 273.37M |
| Revenue/Share | 0.37 |
| Gross Profit | 109.79M |
| EBITDA | 11.55M |
| Net Income | -11.78M |
| Diluted EPS | -0.02 |
Balance Sheet
| Total Cash | 87.82M |
| Total Cash/Share | 0.12 |
| Total Debt | 313.96M |
| Total Debt/Equity | 0.91 |
| Current Ratio | 0.55 |
| Book Value Per Share | 0.47 |
Price History
| 52-Week Change | 13.41 |
| 52-Week High | 1.44 |
| 52-Week Low | 0.67 |
| Moving Average 50 Days | 0.87 |
| Moving Average 200 Days | 1.02 |
Statistics
| Average Volume | 91,777 |
| Shares Outstanding | 739.3M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
